We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Illumina

Illumina develops, manufactures and markets integrated systems for the analysis of genetic variations and biological ... read more Featured Products: More products

Download Mobile App




New Genetic Disease Identified in Children

By LabMedica International staff writers
Posted on 09 Apr 2014
Print article
Image: HiSeq2000 sequencing platform (Photo courtesy of Illumina).
Image: HiSeq2000 sequencing platform (Photo courtesy of Illumina).
A new genetic disease that causes neurologic, muscle, eye and liver problems in children has been identified by a combination of modern gene-sequencing techniques.

Mutations in the gene coding for N-glycanase 1 (NGLY1), an enzyme that recycles defective products from a cellular assembly line, was found in children who have varying degrees of movement disorders, including a characteristic combination of muscle contractions that causes abnormal tremulous movements.

Scientists at Lucile Packard Children’s Hospital (Palo Alto, CA, USA) and an international team of collaborators found eight children who through case reports and social media had clinical symptoms similar to an initial case and were found in a matter of months. All patients had global developmental delay, a movement disorder, and hypotonia. Other common findings included hypolacrima or alacrima (7/8), electroencephalography (EEG) abnormalities (7/8), elevated liver transaminases (6/7), microcephaly (6/8), abnormal brain imaging (6/8), diminished reflexes (6/8).

Exome sequencing was performed in the different collaborating laboratories using the HiSeq2000 platform (Illumina; San Diego, CA, USA) and the SureSelect Human All Exon 50 Mb Kit (Agilent; Santa Clara CA, USA) and for all patients, variants were confirmed by Sanger sequencing. The nonsense mutation c.1201A>T (p.R401X) was the most common deleterious allele identified, present in the homozygous state in five of eight cases and in the compound heterozygous state in one case. Two patients did not carry the c.1201A>T (p.R401X) mutation and their clinical phenotype was relatively mild by comparison.

The study confirmed that children with a defective NGLY1 gene do not make the N-glycanase enzyme. The scientists also observed that the children's liver biopsies contained an amorphous substance, which they suspected was an accumulation of protein that did not get recycled. Gregory Enns, MB, ChB, an associate professor of genetics in pediatrics and co-lead author, said, “This represents a complete change in the way we're going about clinical medicine. This is happening so quickly because of the integration of the families with the scientists, and because so many people are coming at this from so many angles.” The study was published on March 20, 2014, in the journal Genetics in Medicine.

Related Links:

Lucile Packard Children’s Hospital
Illumina
Agilent


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.